Seeking Alpha

Merck (MRK +1.9% premarket) says one of its two migraine drugs was largely safe and effective in...

Merck (MRK +1.9% premarket) says one of its two migraine drugs was largely safe and effective in a Phase III trial, but pulled the second due to reports of liver problems. (PR)
Comments (2)
  • overbet
    , contributor
    Comments (37) | Send Message
     
    no shares have traded in mrk yet. how can it be up? and there is no active market. the best bid is down .20 from pc
    10 Sep 2009, 09:12 AM Reply Like
  • Tony Petroski
    , contributor
    Comments (6373) | Send Message
     
    I agree with overbet. What is the source of this premarket move?
    10 Sep 2009, 09:20 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|